Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID
Aug 10, 2022
SEOUL, South Korea , Aug. 10, 2022 /PRNewswire/ -- Panacell Biotech Co., Ltd. said that NK cells, exosomes, and brown adipose-derived stem cells are effective to treat patients with long COVID conditions, or post COVID-19 conditions, as well as those with terminal illness. Seung-Ho Choi, CEO of Panacell Biotech Panacell Biotech is South Korea's research institute specializing in advanced r...